Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine during anesthesia induction for prevention of postoperative depression in thyroid cancer surgery
ChiCTR2200063302Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in thyroid cancer, major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Self-Rating Anxiety Scale score, Self-Rating Depression Scale score and 3 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
thyroid cancermajor depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2200063302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063302.